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Calponin is a thin filament-associated protein in smooth muscle that has been shown to bind actin, tropomyosin and cahnodulin, and has been 
implicated to play a role in regulation of smooth muscle contractility. Using a centrifugation assay we found that calponin interacts with 
unphosphorylated hlamentous mooth muscle myosin. We found that this calponin-myosin interaction is reversed by Ca2+-CaM, and depends on 
ionic strength. At 50 mM NaCl the binding constant and the stoichiometry of this interaction were estimated to be 2 x lo6 M-l, and 1.2-2.4 calponin 
per myosin, respectively. We suggest hat the calponin-myosin interaction could be involved in regulation of smooth muscle contractility by 
anchoring myosin to actin. 
Calponin; Myosin; Smooth muscle 
1. INTRODUCTION 
Calponin is a 33 kDa thin filament-associated protein 
that has been suggested to play a role in regulation of 
smooth muscle contractility [1,2]. It is known to be 
capable of binding to actin, tropomyosin and CaM 
[1,3,4], and of inhibiting the actin-activated myosin 
ATPase activity [2,5]. This inhibitory effect of calponin 
was found to be reversed upon the addition of Ca2+- 
CaM [S] or by phosphorylation [2]. Calponin has also 
been shown to inhibit actin translocation over myosin 
heads in in vitro motility assays [6,7]. It was also found 
that calponin enhances the affinity between actin and 
myosin in in vitro motility assay [7], raising the possibil- 
ity that calponin interacts directly with myosin as well 
as with actin. The mechanism whereby calponin inhibits 
actomyosin ATPase is still under investigation [5,8,9]. 
Although it is commonly assumed that the inhibitory 
effect is exerted via actin, it has been suggested that it 
can also occur via a direct interaction between calponin 
and myosin [8]. 
50 mM NaCl. The binding constant and stoichiometry 
of this interaction was estimated to be 2 x lo6 M-’ and 
1.2-2.4 calponin per molecule of myosin, respectively. 
We speculate that calponin may function to anchor 
myosin to actin in smooth muscle contractility. 
2. MATERIALS AND METHODS 
2.1. Materials 
Ovalbumin and other commonly used reagents were from Sigma. 
Materials from gel electrophoresis were from BioRad. 
2.2. Proteins 
This study was designed to examine whether calponin 
indeed interacts with smooth muscle myosin directly. 
We found that calponin co-sediments with unphos- 
phorylated, filamentous myosin via an equilibrium 
binding process. This binding is reversed by Ca2’-CaM 
and is weakened at salt concentrations higher than 
GCaN [1] and myosin [lo] were isolated from chicken gizzards. 
CaM and Tn-C were isolated from bovine brain [ 111 and rabbit skel- 
etal muscle [12], respectively. Expression, purification and characteri- 
zation of RctCaN is described elsewhere [13]. Here we briefly mention 
that RccCaN is a non-fusion protein whose amino acid composition 
and N-terminal sequence is identical to that derived from the nucleo- 
tide sequence, and that like GCaN, RaCaN is fully capable of binding 
to Ca’+-CaM, Ca*‘-Tn-C, tropomyosin, actin, and of inhibiting skel- 
etal muscle acto-subfragment-l ATPase activity. Protein concentra- 
tion was determined either by the Lowry method or spectrophotomet- 
rically using Als,,,, values of 2.0 at 276 nm for CaM [14], 11.3 at 
277 nm for calponin [2], 4.5 at 280 nm for myosin [15], and 1.8 at 
280 nm for Tn-C [16]. 
2.3. Sedimentation assay 
*Corresponding author. Fax: (1) (617) 523-6649. 
Abbreviations; CaM, cahnodulin; DlT, dithiothreitol; EGTA, [ethyl- 
enebis(oxyethylenenitrilo)]tetraacetic acid;GCaN, gizzard calponin; 
RcrCaN, recombinant a-isoform of calponin; Tn-C, troponin-C; SDS- 
PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis. 
For most of experiments proteins at a final concentration of 6 PM 
were incubated in 150 ~1 of 20 mM Tris-HCl, 50 mM NaCl, 2 mM 
NaN,, 1 mM DTT, pH 7.5, for 20 min at 4”C, then centrifuged at 
100,000 x g for 20 min at 4’C in a Beckman TL 100 ultracentrifuge. 
Aliquots of the incubation mixtures prior to centrifugation, supema- 
tants and solubilized pellets were then subjected to SDS-PAGE elec- 
trophoresis. 
2.4. Quantification of protein content from bana? on SDS-PAGE gels 
The amounts of materials in the incubates, supematants and pellets 
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were quantified by densitometry using a laboratory-built image anal- 
ysis system. The images of Coomassie blue-stained gels were captured 
using a Dage-MT1 (Michigan City, IN, USA) model CCD-72 camera, 
equipped with high resolution optics. The area under each band was 
then computed using the program IMAGE by Wayne Rosbard dis- 
tributed by the National Institutes of Health, Research Series Branch. 
Standard curves for calponin and myosin were constructed to establish 
the linear concentration range. The 20 kDa myosin light chain was 
used for the calculation of myosin concentration. 
3. RESULTS AND DISCUSSION 
As expected, centrifugation of myosin (6 PM) at 
50 mM NaCl produced complete sedimentation of the 
myosin (Fig. 1, lanes 2-4), since under these conditions 
myosin is in the readily sedimentable filamentous form. 
Under the same conditions ll-32% of RaCaN was 
found in the pellet (Fig. 1; lanes 5-7), indicating RccCaN 
aggregates to a certain extent under these conditions. 
When RczCaN was centrifuged together with myosin 
67-80% of the RaCaN sedimented (Fig. 1, lanes 8-10). 
Similar results were obtained for GCaN (Fig. 1, lanes 
11-16). These results indicate that both GCaN and 
RaCaN can co-sediment with the filamentous form of 
myosin. RcllCaN was used in all further experiments. 
In order to ascertain whether the observed co-sedi- 
mentation of RaCaN and myosin resulted from 
RaCaN-myosin interaction or from occlusion by 
myosin aggregates, we compared the sedimentation 
properties of R&aN with those of ovalbumin and Tn- 
C. Both proteins remained in the supernatant regardless 
of whether they were centrifuged in the presence or 
absence of myosin (data not shown), indicating that 
myosin filaments have no tendency to occlude other 
proteins that are present in solution. 
Since Ca”-CaM is known to reverse the interaction 
between calponin and actin [5], we examined whether 
calponin-myosin interaction is likewise reversible upon 
addition of Ca2+-CaM. Ca2+ alone did not inhibit 
RaCaN-myosin co-sedimentation (Fig. 2, lane 6), but 
Myosin RaCaN 
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the addition of both Ca” and CaM produced nearly 
complete inhibition of RaCaN-myosin co-sedimenta- 
tion (Fig. 2, lane 7). RaCaN-myosin co-sedimentation 
was restored when EGTA was added to chelate Ca” 
(Fig. 2, lane 8). None of the above conditions affected 
sedimentation of RaCaN when centrifuged alone (Fig. 
2, lanes l-3). 
The strength of calponin-myosin interaction was ex- 
amined in the presence of increasing NaCl concentra- 
tion. As expected, complete sedimentation of myosin 
was observed between 50 and 150 mM NaCl (Fig. 3). 
Higher salt concentrations inhibit myosin sedimenta- 
tion, as myosin filaments dissociate into soluble mono- 
mers. The presence of RaCaN has no effect on the 
salt-dependent sedimentation of myosin (data not 
shown). The amount of RcllCaN that co-sediments with 
myosin decreases rapidly with increasing NaCl concen- 
tration: at 150 mM NaCl, only 36% of the added 
RolCaN co-sediments with myosin compared to 75% at 
50 mM NaCl. Within this range of NaCl concentration 
(5&150 mM) the amounts of sedimented myosin and 
RaCaN when centrifuged separately remain relatively 
constant (97-83% for myosin, 2317% for RaCaN). 
These results show that the interaction between RaCaN 
and myosin is salt-dependent; it is relatively strong at 
50 mM NaCl, begins to weaken at 100 mM NaCl, and 
is virtually abolished at 150 mM NaCl. 
The affinity and stoichiometry of the RaCaN- 
myosin interaction were characterized by titrating 
myosin (O-6 yM) into a constant amount of RaCaN (2 
PM) followed by centrifugation. The amounts of 
RaCaN in the incubates prior to centrifugation, in the 
pellets and supematants were then measured by den- 
sitometry (see section 2). Fig. 4 shows that the amount 
of sedimented RaCaN reaches a plateau at high concen- 
trations of myosin, although some amount of RaCaN 
remains in the supematant even at the highest myosin 
concentration that we used. When the data in Fig. 4 
were fitted by a non-linear regression program [17] we 
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Fig. 1. Sedimentation of calponin in the presence and absence of smooth muscle myosin. Coomassie blue-stained 12% SDS-PAGE of: incubates 
before centrifugation (T), pellets (P) and supernatants (S). (Lane 1) Molecular weight standards; (lanes 2-4) myosin alone; (lanes 5-7) RaCaN alone; 
(lanes 8-9) RaCaN plus myosin; (lanes 1 l-l 3) GCaN alone; (lanes 14-16) GCaN plus myosin. Concentrations of all proteins are 6 PM. HC, LCzo 
and LC,, indicate myosin heavy chain, 20 kDa myosin light chain and 17 kDa myosin light chain, respectively. 
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Fig. 2. Effect of Ca”-CaM on RaCaN-myosin co-sedimentation. (Lanes 4 and 5) RaCaN before centrifugation; (lanes l-3) RaCaN in pellets when 
sedimented alone; (lanes 6-8) RaCaN and myosin in pellets when centrifuged together. Incubations were performed with 2 PM RaCaN in the 
presence or absence of 2 ,uM myosin in 100 PM Ca*+ (lanes 1 and 6); 100 PM Ca’+ and 20 PM CaM (lanes 2 and 7), and 100 PM Ca*+, 20 PM 
CaM and 1 mM EGTA (lanes 3 and 8). Assay conditions and symbols are identical to those in Fig. 1. 
obtained a binding constant of 2 x lo6 M-l, and a con- 
centration of myosin at saturation of 0.82 pM. 
The actual stoichiometry of the RaCaN-myosin in- 
teraction could not be determined unequivocally be- 
cause it is not clear how much of the total RaCaN pool 
is capable of binding myosin. If we assume that the 
entire 2 ,uM pool of RaCaN can bind myosin, then the 
RaCaN:myosin stoichiometry would be 2.4. However, 
as shown in Fig. 4, -17% of R&CaN does not sediment 
even at saturating myosin concentrations. Assuming 
that all the remaining RaCaN (1.7 PM) is capable of 
binding to myosin, the RaCaN:myosin stoichiometry 
would be 2.0. The origin of this RcllCaN fraction that 
does not bind myosin is not clear; it is likely to be 
RrxCaN that was denatured during the purification pro- 
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cedure. It is possible that the fraction of RaCaN that 
sediments in the absence of myosin (-34%) is also inca- 
pable of binding myosin. Assuming that the remaining 
fraction of R&CaN (1.3 ,uM) is the only pool that can 
bind myosin, the RaCaN:myosin stoichiometry would 
be 1.2. Although the stoichiometry of the RaCaN- 
myosin interaction cannot be determined precisely in 
these experiments, it appears to fall within a reasonable 
range of either one RaCaN per molecule of myosin (480 
kDa) or one RaCaN per mole of myosin heavy chain. 
In summary, our results show that calponin can bind 
to unphosphorylated, filamentous form of smooth mus- 
cle myosin. This interaction is reversible by Ca*‘-CaM. 
The strength of the interaction depends on NaCl con- 
centration, being relatively strong at 50 mM NaCl and 
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Fig. 3. Saltdependent sedimentation of myosine alone (open circles), RaCaN alone (closed diamonds) and RaCaN in the presence of myosin (closed 
squares). The abscissa is the amount of RaCaN in pellet divided by the total amount. Each value represents the mean of 2-4 separate xperiments. 
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Fig. 4. Sedimentation of RaCaN (2pM) with the increasing concentrations of myosin (0-6,~M). The abscissa is the difference between total amount 
of RaCaN in the incubation mixture and the amount that remained in the supematant, divided by the total amount. Each value represents the 
average of two independent experiments. The line represents the best fit obtained by non-linear regression [17]. 
virtually undetectable at 150 mM NaCl. The binding 
constant between RaCaN and myosin is approximately 
2 x IO6 M-’ mM NaCl. The stoichiometry of this inter- 
action is in the range of 1.2-2.4 RaCaN per myosin. 
The physiological significance of this interaction is 
not clear at this point. It suggests, however, that CaN 
can bind to both myosin and actin, so that it may play 
a role in regulation of smooth muscle contractility by 
anchoring myosin to actin. This is the first report de- 
scribing a direct interaction between calponin and 
myosin. Further studies directed towards clarifying the 
physiological significance of this interaction are in pro- 
gress. 
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